an elisa for the anti-cancer drug vp16 in unextracted plasma has been developed using vp16-thyroglobulin-coated microtitre plates , a sheep anti-vp16 serum , and a donkey anti-sheep hrpo-labelled second antibody .
C0032105
plasma
C0229671
serum